Show simple item record

dc.contributor.authorWang, Shuangkuai
dc.contributor.authorTong, Yuantao
dc.contributor.authorZong, Hui
dc.contributor.authorXu, Xuewen
dc.contributor.authorCrabbe, M. James C.
dc.contributor.authorWang, Ying
dc.contributor.authorZhang, Xiaoyen
dc.date.accessioned2022-02-21T09:46:41Z
dc.date.available2022-02-18T00:00:00Z
dc.date.available2022-02-21T09:46:41Z
dc.date.issued2022-02-17
dc.identifier.citationWang S, Tong Y, Zong H, Xu X, Crabbe MJC, Wang Y, Zhang X (2022) 'Multi-level analysis and identification of tumor mutational burden genes across cancer types', Genes, 13 (2), pp.365-.en_US
dc.identifier.issn2073-4425
dc.identifier.pmid35205408
dc.identifier.doi10.3390/genes13020365
dc.identifier.urihttp://hdl.handle.net/10547/625325
dc.description.abstractTumor mutational burden (TMB) is considered a potential biomarker for predicting the response and effect of immune checkpoint inhibitors (ICIs). However, there are still inconsistent standards of gene panels using next-generation sequencing and poor correlation between the TMB genes, immune cell infiltrating, and prognosis. We applied text-mining technology to construct specific TMB-associated gene panels cross various cancer types. As a case exploration, Pearson’s correlation between TMB genes and immune cell infiltrating was further analyzed in colorectal cancer. We then performed LASSO Cox regression to construct a prognosis predictive model and calculated the risk score of each sample for receiver operating characteristic (ROC) analysis. The results showed that the assessment of TMB gene panels performed well with fewer than 500 genes, highly mutated genes, and the inclusion of synonymous mutations and immune regulatory and drug-target genes. Moreover, the analysis of TMB differentially expressed genes (DEGs) suggested that JAKMIP1 was strongly correlated with the gene expression level of CD8+ T cell markers in colorectal cancer. Additionally, the prognosis predictive model based on 19 TMB DEGs reached AUCs of 0.836, 0.818, and 0.787 in 1-, 3-, and 5-year OS models, respectively (C-index: 0.810). In summary, the gene panel performed well and TMB DEGs showed great potential value in immune cell infiltration and in predicting survival.en_US
dc.description.sponsorshipThis work was funded by the National Natural Science Foundation of China [No: 81972914, Funder: Xiaoyan Zhang; No: 81573023, Funder: Xiaoyan Zhang], the Fundamental Research Funds for the Central Universities [No: 22120200014, Funder: Xiaoyan Zhang], Shanghai “Rising Stars of Medical Talent” Youth Development Program [No: 2019-72, Funder: YingWang], and the National Key R&D Program of China [No: 2016YFC1303200, Funder: Xiaoyan Zhang].en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.urlhttps://www.mdpi.com/2073-4425/13/2/365en_US
dc.rightsGreen - can archive pre-print and post-print or publisher's version/PDF
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectcanceren_US
dc.subjectiManageCanceren_US
dc.subjectimmunotherapyen_US
dc.subjectSubject Categories::C550 Immunologyen_US
dc.titleMulti-level analysis and identification of tumor mutational burden genes across cancer typesen_US
dc.typeArticleen_US
dc.contributor.departmentTongji Universityen_US
dc.contributor.departmentOxford Universityen_US
dc.contributor.departmentSecond Military Medical Universityen_US
dc.contributor.departmentUniversity of Bedfordshireen_US
dc.contributor.departmentShanxi Universityen_US
dc.identifier.journalGenesen_US
dc.identifier.pmcidPMC8872466
dc.date.updated2022-02-21T09:41:23Z
dc.description.notegold open access


Files in this item

Thumbnail
Name:
genes-13-00365(5).pdf
Size:
3.553Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Green - can archive pre-print and post-print or publisher's version/PDF
Except where otherwise noted, this item's license is described as Green - can archive pre-print and post-print or publisher's version/PDF